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Fanny Janssen*
Smoking is the leading preventable risk factor of mortality in Europe, and its share of 
all-cause mortality is particularly high compared to other world regions. Fanny Janssen 
analyses the impact of smoking on mortality levels and trends in Europe and examines how 
variations in smoking and smoking-attributable mortality by sex and between countries 
explain differences in life expectancy.    
Smoking’s impact on mortality in Europe
More than a billion people, or 22% 
of  the world population aged 15 and 
older, smoked tobacco in 2016 [1]. In 
the most developed countries, 
smokers have mortality rates 2–3 
times higher than non-smokers and 
live on average 6–10 years less [2]. 
According to the most recent Global 
Burden of  Disease estimates, 
smoking caused about 6.4 million 
deaths globally in 2015, or about 
11% of  all deaths [3]. Smoking thus 
exacts a heavy toll, particularly 
among those aged 30–69.
Smoking prevalence, however, 
differs greatly between countries, 
between men and women, and over 
time. Consequently, smoking’s 
impact on mortality levels and 
trends also varies significantly. The 
smoking epidemic model [4, 5] describes these 
differences. Smoking prevalence first increases, then 
declines, and a similar wave pattern in smoking-
attributable mortality follows about 30 years later. 
The smoking epidemic started among men in North 
American, Australasian, and North-Western 
European countries, followed by men in other 
European countries, then China, Japan, Southeast 
Asia, Latin America, North Africa, and, finally, sub-
Saharan Africa. It occurred several decades later 
among women, but their smoking prevalence levels 
have remained lower than those of  men [4].
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Coverage: Twenty-nine European countries with long-term data series (see Figure 3).
Year: 2014 except for Bulgaria (2010), Greece (2013), and Ukraine (2012). 
Source: Author’s calculations based on data from the WHO Mortality Database, the ACS 
CPS-II, and the Human Mortality Database (see Box 1).
Figure 1. Smoking-attributable mortality fractions in Europe in 2014  (%) 
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In Europe, smoking is currently the leading 
preventable risk factor of  mortality [6]. At 29%, this 
global region has the highest tobacco smoking 
prevalence among adults [1]. The share of  all-cause 
mortality due to smoking among those over age 30 
is 16% in Europe [7], which is about 5% higher than 
the global average.
Sex and country differences 
Because the timing of  the smoking epidemic in 
Europe has varied by sex and subregions, clear 
differences in smoking-attributable mortality levels 
were observed in 2014 (Figure 1).
For men, the share of  mortality due to smoking 
ranged from 9% (Sweden) to 35% (Hungary) and 
was 20% on average for the 29 European countries 
examined here. For women, this share was 
substantially lower, ranging from 0.1% (Belarus) 
to 22% (Denmark), with an average level of  8%. 
For men, it was higher in Eastern European 
countries than in the rest of  Europe (27% vs. 17% 
on average). Among women, however, it was 
higher in North-Western European countries 
(11%) than elsewhere (6%).
The smoking epidemic is therefore most advanced 
in Nor th-Wester n Europe,  with smok ing-
attributable mortality already abating among men 
but still nearing its peak among women (see also 
Figure 2) [8]. The early onset of  the smoking 
epidemic in North-Western European countries can 
be explained by the early automation of  the cigarette 
production process in these countries, facilitated by 
their high income levels [8]. 
Smoking’s effect on life expectancy levels 
These substantial levels of  smoking-attributable 
mortality are having a clear impact on levels of  life 
expectancy throughout Europe, and explain 
important differences therein across countries and 
between men and women.
Figure 3 shows country- and sex-specific estimates 
of  the potential gain (the added years) in life 
expectancy at birth (PGLE) if  smoking were 
eliminated (see Box 2). In 2014, PGLEs ranged from 
0.9 years (Sweden) to 5.3 years (Hungary) among 
men, with an average of  2.7 years; and from 0.01 
years (Belarus) to 2.5 years (Hungary) among 
women, with an average of  1.0 years. For France, 
PGLEs were 2.7 and 0.7 years among men and 
women, respectively.
In Europe, the difference in PGLEs between men 
and women is 1.7 years on average. This difference 
is highest in Eastern European countries, but 
women exhibit higher PGLEs in the forerunner 
countries of  Denmark, Ireland, Sweden, United 
Kingdom, and Iceland. On average, the sex difference 
in life expectancy in the 29 European countries 
studied was 6.0 years. Thus, on average, smoking 
contributed 28% (1.7 ÷ 6.0) to the sex difference in 
life expectancy.
Smoking also contributed to life expectancy 
differences between countries. Figure 3 shows that 
in 2014, the ordering of  countries by PGLEs for men 
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Source: Author’s calculations based on data from the WHO 
Mortality Database, the ACS CPS-II, and the Human Mortality 
Database (see Box 1).
Figure 2. Trends in smoking-attributable 
mortality fractions in selected European 
countries, 1950–2014
Coverage: Twenty-nine European countries with long-term data 
series.
Year: 2014 except for Bulgaria (2010), Greece (2013), and Ukraine 
(2012).
Source: Author’s calculations based on data from the WHO 
Mortality Database, the ACS CPS-II, and the Human Mortality 
Database (see Boxes 1 and 2).
Figure 3. Potential gain in life expectancy after 
excluding mortality from smoking, 2014
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(from high to low) closely resembles the ordering 
of  countries by overall life expectancy levels (from 
low to high). For men, the difference in life 
expectancy between Hungary (72.3 years) and 
Sweden (80.4 years) was 8.1 years. This difference 
would have been 3.7 years had smoking not occurred. 
For women, the opposite pattern is observed, as the 
smoking epidemic currently results in smaller 
differences between countries due to higher 
smoking-attributable mortality in Western Europe 
than in Eastern Europe. In 2014, women’s life 
expectancy was 3.8 years higher in Western Europe 
than in Eastern Europe. This difference would have 
been 4.1 years if  smoking had not occurred.
Smoking’s effect on the evolution of life 
expectancy 
The 2014 levels reflect the current phase of  the 
smoking epidemic for men and women in the 
countries studied. The smoking epidemic, however, 
evolves in a wave pattern, first with an increase in 
smoking-attributable mortality, then a decline 
(Figure 2). Figure 4 reveals how this wave pattern 
affects the evolution in PGLEs due to smoking. In 
this Figure, the PGLE represents the difference 
between life expectancy for non-smoking-related 
mortality and life expectancy for all-cause mortality. 
For men, the PGLE first increased and then declined. 
For Danish and Dutch men, the peak in PGLEs 
occurred around 1980 at 4.2 and 5.2 years, respectively. 
For French men, the PGLE was highest around 1987 
at 4.0 years. For men in Spain, Hungary, and Ukraine, 
the peak occurred in the 1990s, with values over 6.0 
years for Hungary and Ukraine. The above reflects 
the spread of  the smoking epidemic from North-
Western to Southern Europe and then to Eastern 
Europe. For women in most countries, the PGLE is 
still increasing (North-Western European countries), 
or has begun to do so recently (Southern and Eastern 
Europe), and PGLE levels are low. In Denmark, 
however, women’s PGLE levels have become higher 
than men’s, and for the Netherlands and other 
forerunner North-Western European countries, this 
is expected to occur soon.
Figure 4 also reveals the impact of  smoking on trends 
in life expectancy over time. For men in the Netherlands, 
Denmark, and other Nordic countries, the increase in 
life expectancy stagnated in the 1950s and 1960s, but if  
we exclude smoking-related mortality, the stagnation 
largely disappears. Similarly, among Danish and Dutch 
women in the 1980s and 1990s, the stagnation disappears 
when considering non-smoking-related mortality. 
Among men in other European countries, and women 
in other North-Western European countries and 
selected Eastern European countries, the increase in life 
expectancy would have been greater if  smoking were 
eliminated. Finally, if  we consider only non-smoking-
related mortality, the increase in men’s life expectancy 
becomes more similar to that of  women.
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Source: Author’s calculations based on data from the WHO 
Mortality Database, the ACS CPS-II, and the Human Mortality 
Database (see Boxes 1 and 2).
Figure 4. Life expectancy trends including and 
excluding mortality from smoking, selected 
countries, 1950–2014  
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Keywords
In Europe, the smoking epidemic has clearly affected 
mortality levels and trends, as well as differences therein 
between countries and sexes. In 2014, smoking reduced 
the life expectancy levels of European countries on 
average by 2.7 years among men and by 1.0 years among 
women, and smoking contributed 28% to the sex difference 
in life expectancy. The smoking epidemic is most advanced 
in North-Western Europe, where smoking-attributable 
mortality is abating among men but still nearing its peak 
among women, resulting in small differences between 
both sexes. If we eliminate smoking-related mortality, life 
expectancy would not have stagnated in countries like 
Denmark and the Netherlands in the 1950s and 1960s 
among men and in the 1980s and 1990s among women. 
Generally, without smoking, life expectancy would have 
increased more strongly and in a more similar manner 
among men and women.
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Box 1. Smoking-attributable mortality 
Smoking-attributable mortality fractions (the share of 
mortality due to smoking) by country, year, sex, and age 
are estimated using a simplified version of the indirect 
method developed by Peto et al. (1992) [9, 10]. This method 
uses observed lung cancer mortality rates, controlled for 
the part not due to smoking, as a proxy for lifetime smoking 
prevalence. Smoking-attributable mortality fractions are 
then obtained by applying to this prevalence relative risks 
(RRs) of death from all causes combined for a smoker 
compared to a non-smoker. The method takes into account 
that smoking affects not just lung cancer mortality but also 
deaths from other causes. See Janssen (2019) for an 
appraisal of this method’s pros and cons [8].
Age- and sex-specific lung cancer deaths were obtained 
mainly from the World Health Organization Mortality 
Database (updated 11 April 2018). The age- and sex-specific 
RRs as well as the information used to obtain non-smoking-
related lung cancer mortality are derived from the American 
Cancer Society’s Cancer Prevention Study II (ACS CPS-II) [9].
To estimate the share of all-cause mortality due to smoking 
for all ages combined for each country and year, age- and 
sex-specific smoking-attributable deaths were obtained by 
multiplying this category’s share of mortality due to 
smoking by its all-cause mortality numbers (downloaded 
from the Human Mortality Database on 20 July 2018). Then, 
for each country and year, the smoking-attributable deaths 
were summed over all ages and divided by the all-cause 
deaths for all ages combined.
To assess the impact of smoking-attributable mortality 
on life expectancy levels and trends (see Box 2), non-
smoking-attributable mortality rates were estimated by 
multiplying age- and sex-specific all-cause mortality rates 
by 1 minus the age- and sex-specific smoking-attributable 
mortality fractions.
Box 2. Life expectancy levels and 
trends if smoking were eliminated
The effect of smoking on life expectancy is illustrated by 
the potential gain in life expectancy (PGLE) if smoking were 
eliminated. It is estimated by subtracting the normal life 
expectancy level from the life expectancy level if all deaths 
due to smoking were avoided. The latter life expectancy 
levels are obtained by constructing life tables based on 
non-smoking-attributable mortality rates, rather than all-
cause mortality rates.
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